INTELLIA THERAPEUTICS INC

Ticker: NTLA CUSIP: 45826J105 Class: Common Stock

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023

Shares 164,627 Value ($000) $6,136 Avg Close $39.22 Range $32.44 - $46.03

Q4 2021

Shares 53,200 Value ($000) $6,290 Avg Close $125.27 Range $91.99 - $143.92

Q3 2021

Shares 53,200 Value ($000) $7,137 Avg Close $151.40 Range $125.68 - $180.59

Q1 2021

Shares 72,500 Value ($000) $5,818 Avg Close $67.12 Range $43.86 - $92.00

Q2 2020

Shares 137,100 Value ($000) $2,882 Avg Close $16.99 Range $11.02 - $24.32

Q1 2020

Shares 262,100 Value ($000) $3,205 Avg Close $13.47 Range $9.18 - $15.84

Q4 2019

Shares 262,100 Value ($000) $3,845 Avg Close $13.91 Range $10.26 - $17.80

Q3 2019

Shares 327,600 Value ($000) $4,373 Avg Close $15.94 Range $12.80 - $19.00

Q2 2019

Shares 327,600 Value ($000) $5,363 Avg Close $15.72 Range $13.72 - $18.66

Q1 2019

Shares 377,600 Value ($000) $6,449 Avg Close $14.91 Range $12.68 - $17.76

Q4 2018

Shares 377,600 Value ($000) $5,154 Avg Close $18.59 Range $11.03 - $28.62

Q3 2018

Shares 744,600 Value ($000) $21,310 Avg Close $29.09 Range $24.80 - $32.95

Q2 2018

Shares 876,000 Value ($000) $23,967 Avg Close $24.23 Range $19.51 - $31.68

Q1 2018

Shares 1,113,000 Value ($000) $23,473 Avg Close $24.59 Range $18.26 - $35.99

Q4 2017

Shares 2,337,684 Value ($000) $44,930 Avg Close $23.09 Range $16.33 - $33.34

Q3 2017

Shares 2,662,180 Value ($000) $66,155 Avg Close $18.84 Range $14.45 - $26.70

Q2 2017

Shares 2,662,180 Value ($000) $42,595 Avg Close $13.97 Range $11.15 - $17.61

Q1 2017

Shares 2,662,180 Value ($000) $37,510 Avg Close $13.42 Range $10.83 - $15.78

Q4 2016

Shares 2,662,180 Value ($000) $34,901 Avg Close $15.02 Range $11.87 - $19.66

Q3 2016

Shares 2,662,180 Value ($000) $45,310 Avg Close $19.36 Range $16.60 - $24.90

Q2 2016

Shares 2,662,180 Value ($000) $56,838 Avg Close $26.61 Range $20.70 - $30.40

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2023	164,627	$6,136	$39.22	$32.44 - $46.03
Q4 2021	53,200	$6,290	$125.27	$91.99 - $143.92
Q3 2021	53,200	$7,137	$151.40	$125.68 - $180.59
Q1 2021	72,500	$5,818	$67.12	$43.86 - $92.00
Q2 2020	137,100	$2,882	$16.99	$11.02 - $24.32
Q1 2020	262,100	$3,205	$13.47	$9.18 - $15.84
Q4 2019	262,100	$3,845	$13.91	$10.26 - $17.80
Q3 2019	327,600	$4,373	$15.94	$12.80 - $19.00
Q2 2019	327,600	$5,363	$15.72	$13.72 - $18.66
Q1 2019	377,600	$6,449	$14.91	$12.68 - $17.76
Q4 2018	377,600	$5,154	$18.59	$11.03 - $28.62
Q3 2018	744,600	$21,310	$29.09	$24.80 - $32.95
Q2 2018	876,000	$23,967	$24.23	$19.51 - $31.68
Q1 2018	1,113,000	$23,473	$24.59	$18.26 - $35.99
Q4 2017	2,337,684	$44,930	$23.09	$16.33 - $33.34
Q3 2017	2,662,180	$66,155	$18.84	$14.45 - $26.70
Q2 2017	2,662,180	$42,595	$13.97	$11.15 - $17.61
Q1 2017	2,662,180	$37,510	$13.42	$10.83 - $15.78
Q4 2016	2,662,180	$34,901	$15.02	$11.87 - $19.66
Q3 2016	2,662,180	$45,310	$19.36	$16.60 - $24.90
Q2 2016	2,662,180	$56,838	$26.61	$20.70 - $30.40